# CAN SLIM Progress Board

Last updated: 2026-09-14

Frozen quantitative v1 remains research-complete but not production-ready. FWD1 and EXH2 continue unchanged. The theory-fidelity path now has frozen contracts through #44. #43 remains the current lifecycle arbiter for the three frozen executable exit channels (#37/#40/#42); #44 adds climax/exhaustion evidence only and does not alter lifecycle execution.

## Repository boundary for #33

**Canonical #33 implementation and P8 morphology validation live in `azharmz/ussy-oneil-patterns`.**

Frozen production contract: `oneil-pattern-output-v2` with only `FLAT_BASE`, `DOUBLE_BOTTOM`, `CUP_WITHOUT_HANDLE`, and `CUP_WITH_HANDLE`. P6 advanced patterns remain excluded and frozen.

## Theory Fidelity / v2 path

| # | Workstream | Status |
|---:|---|---|
| 25 | Theory Fidelity Audit | **COMPLETE** |
| 26 | Proper-base definitions | **COMPLETE** |
| 27 | Pivot / buy-point definition | **COMPLETE** |
| 28 | Breakout + volume confirmation | **COMPLETE** |
| 29 | RS / leadership fidelity | **COMPLETE** |
| 30 | C/A/S/I/M role fidelity | **COMPLETE** |
| 31 | Sell / risk-management fidelity | **COMPLETE** |
| 32 | Theory-faithful candidate specification | **COMPLETE / FROZEN v1** |
| 33 | O'Neil Pattern Recognition Engine | **CORE COMPLETE / FROZEN — P8 CONDITIONAL PASS** |
| 34 | Theory-faithful candidate generator | **COMPLETE / FROZEN v1** |
| 35 | New-candidate validation | **COMPLETE / FROZEN — CONDITIONAL PASS** |
| 36 | Execution / entry research | **BASELINE FROZEN / DIAGNOSTIC COMPLETE / PRIMARY PERFORMANCE VALIDATION BLOCKED_ON_ELIGIBLE_POPULATION** |
| 37 | Sell / risk execution semantics | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 38 | Technical deterioration evidence | **EVIDENCE LAYER COMPLETE / FROZEN v1** |
| 39 | Weekly aggregation / 10-week evidence | **WEEKLY AGGREGATION + 10W EVIDENCE COMPLETE / FROZEN v1** |
| 40 | Technical deterioration action semantics | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 41 | Position lifecycle / exit arbiter | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 42 | Round-trip sell action semantics | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 43 | Position lifecycle / exit arbiter v2 | **IMPLEMENTATION COMPLETE / FROZEN v2** |
| 44 | Climax / exhaustion evidence | **EVIDENCE LAYER COMPLETE / FROZEN v1** |

## #34–#35 candidate and validation state

Frozen candidate stages remain:

```text
BASE_RECOGNIZED
→ PIVOT_DEFINED
→ PIVOT_CROSSED
→ BREAKOUT_CONFIRMED
→ CANSLIM_ELIGIBLE
```

#34 final verification run `34758050282` → **SUCCESS**, 9 tests. #35 canonical historical run `34763920536` produced 265,642 observations with zero V35-A/B/C findings and a frozen 60-case corpus. Independent source-evidence audit `34765922653` → **SUCCESS**, C/A/L/M 60/60 MATCH and PIT violations = 0. #35 remains `CONDITIONAL PASS` solely with upstream #33 morphology debt preserved.

## #36 — Entry

Canonical `36-execution-entry-v1` remains frozen: eligible signal known after close T, earliest daily-EOD causal execution convention T+1 open, fill only inside pivot through pivot*1.05. T/T+1/T+3 are dataset/backtest clocks, not O'Neil terminology.

Semantic validation `34785545504` → **SUCCESS, 11 passed**. Variant integrity `34785658367` → **SUCCESS**. Primary performance validation remains `BLOCKED_ON_ELIGIBLE_POPULATION` because canonical #35 has 0 `CANSLIM_ELIGIBLE` observations.

## #37 — Sell / Risk

`37-sell-risk-v1` remains frozen with practical ~7% capital protection from actual fill, legacy 8% severity evidence, observed-open gap-through handling, +20%-25% profit-management state from pivot without automatic full exit, and exceptional-winner/eight-week context.

Semantic validation `34787905360` → **SUCCESS, 10 passed**.

## #38 — Daily Deterioration Evidence

`38-technical-deterioration-evidence-v1` remains evidence-only: MA10/21/50, strict-below-MA breaks, prior-50 volume ratio, project-consistent >=1.40x heavy-volume proxy, largest down-volume evidence, below-pivot and loss-from-fill evidence.

Semantic validation `34788119495` → **SUCCESS, 12 passed**.

## #39 — Weekly / 10-Week Evidence

`39-weekly-10w-evidence-v1` remains frozen: completed ISO-week aggregation, holiday-shortened weeks, weekly OHLCV, true 10-completed-week MA, strict-below break, prior-10 weekly volume ratio and post-week causality. MA50 daily is not treated as identical to the 10-week line.

Semantic validation `34788414986` → **SUCCESS, 10 passed**.

## #40 — Technical Deterioration Action

`40-technical-deterioration-action-v1` remains frozen. Canonical trigger is completed weekly close below MA10w with weekly volume above the prior-10 completed-week average. Low-volume breaks remain evidence. Execution is the first observed trading-session open after the completed signal week. Semantic validation `34789559782` → **SUCCESS**.

## #41 — Position Lifecycle v1

`41-position-lifecycle-exit-arbiter-v1` remains frozen historical integration for #37 + #40 only. Canonical semantic-validation run `34790106465` / job `103812624227` → **SUCCESS, 11 passed in 0.03s**.

## #42 — Round-Trip Sell Action

`42-round-trip-sell-action-v1` remains frozen. Canonical semantics: prior completed-session max high >= pivot*1.10, followed by a later completed daily close <= pivot, then execution at first later observed session open. Same-bar first +10% plus return-to/below-pivot remains explicit ambiguity. Canonical run `34793348883` / job `103821631323` → **SUCCESS, 10 passed in 0.03s**.

## #43 — Position Lifecycle / Exit Arbiter v2

Contract: `43-position-lifecycle-exit-arbiter-v2`.

#43 integrates #37 capital protection, #40 technical deterioration and #42 round-trip. Different dates use earliest executable date. Same-session observed-open exits converge only if their price agrees; conflicting claimed open prices become `NOT_EVALUABLE_SOURCE_CONFLICT`; session-open execution precedes same-date #37 stop convention; otherwise unsupported ordering remains explicit ambiguity.

Canonical run `34796938374` / job `103831748596` → **SUCCESS, 11 passed in 0.03s**.

Freeze decision: `docs/decisions/2026-09-14-43-position-lifecycle-v2-freeze.md`.

## #44 — Climax / Exhaustion Evidence

Specification: `docs/methodology/44-climax-exhaustion-evidence-spec-v1.md`.

Contract: `44-climax-exhaustion-evidence-v1`.

Frozen evidence channels:
- strict largest close-to-close up-day point gain since breakout;
- strict heaviest daily volume since breakout;
- 7-of-8 completed-session up-day sequence;
- 8-of-10 completed-session up-day sequence;
- raw exhaustion gap where current low > prior high;
- weekly range and strict largest weekly range since breakout when weekly bars are supplied;
- explicit completed-session/week chronology since breakout;
- prior-advance context recorded but not promoted to a universal 12/18-week action rule because current production lineage lacks a canonical base-stage contract.

#44 is **evidence-only**. It creates no fourth executable exit and does not modify #43.

EXH2 remains a separate prospective diagnostic. Its `5.33333333333332%` extreme-shock boundary and T+1 rejection mechanism are not imported into #44.

Implementation:
- `src/canslim_research/climax_exhaustion_evidence_v1.py`
- `tests/test_climax_exhaustion_evidence_v1.py`
- `.github/workflows/44-climax-exhaustion-evidence-v1.yml`

Canonical semantic-validation run:
- run `34797449482`
- job `103833195506`
- commit `4697283dbd57c5cc15b5ac7d718f9d6a551ed85b`
- **SUCCESS**
- **10 passed in 0.03s**

Freeze decision: `docs/decisions/2026-09-14-44-climax-exhaustion-evidence-freeze.md`.

Terminal state: `EVIDENCE LAYER COMPLETE / FROZEN v1`.

## Current end-to-end frozen lifecycle

```text
#33 pattern
→ #34 candidate
→ #35 independent validation
→ #36 executable entry
→ OPEN POSITION
→ #37 capital protection
   OR #38/#39/#40 technical deterioration
   OR #42 round-trip
→ #43 lifecycle v2 arbitration
→ CLOSED POSITION

#44 climax/exhaustion = frozen evidence sidecar only
```

## Forward / production boundaries

FWD1 remains LIVE / ACCUMULATING with its existing gate; EXH2 remains separate and prospective. Production integration remains blocked by the FWD1 gate. Theory-fidelity findings must not be retrofitted into FWD1/X3/EXH2.

## Active work from here

1. Keep #33-#44 frozen.
2. Primary lifecycle/performance validation remains blocked until a genuine frozen `CANSLIM_ELIGIBLE` population exists.
3. Do not tune #36 entry, #37 stop, #40 deterioration, #42 round-trip, #43 arbitration or #44 evidence from historical returns.
4. A canonical climax action is not yet authorized; it requires a separate specification resolving prior-advance/base-stage context and exact evidence-combination semantics.
5. Remaining independent theory module after #44 is market-exposure action.
6. Any newly validated executable exit must enter via a new lifecycle version; do not mutate #43 v2.
7. Preserve #33 morphology debt, keep P6 out of production, and keep FWD1/EXH2 unchanged.